🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 2, randomized, double-masked, placebo-controlled, parallel-...
Status
Completed
Location
Meir Hospital
Start Date
2007-01
Trial ID
NCT00349466
Eligible patients with dry eye will be treated with CF101 or placebo twice ...
Status
Completed
Location
Bnei Zion Medical Center
Start Date
2011-07
Trial ID
NCT01235234
Treatments Being Tested
This study will test the hypothesis that CF101, which is under development ...
Status
Completed
Location
Haemek Medical Center
Start Date
2007-06
Trial ID
NCT00428974
This study will test the hypothesis that CF101, administered orally, will r...
Status
Completed
Location
Specialized Hospital for Active Treatment for Eye Diseases "Zrenie"
Start Date
2010-10
Trial ID
NCT01033422
Treatments Being Tested
This is a Phase 2, randomized, double-masked, placebo-controlled study subj...
Status
Withdrawn
Location
Bnei-Zion Medical Center
Start Date
2019-01
Trial ID
NCT01905124
This trial will test the hypothesis that the administration of CF101, a nov...
Status
Terminated
Location
Can-Fite Investigational Site #252
Start Date
2017-10-30
Trial ID
NCT02647762
Treatments Being Tested
This study will test the effectiveness of CF101 in treating the symptoms of...
Status
Withdrawn
Location
Barzilai Medical Center
Start Date
2018-11
Trial ID
NCT00837291
This trial will test the hypothesis that the administration of CF101, a nov...
Status
Completed
Location
Multiprofile Hospital for Active Treatment
Start Date
2010-10
Trial ID
NCT01034306
Treatments Being Tested
This trial will test the hypothesis that the addition of CF101, a novel ant...
Status
Completed
Location
Clinic of Rheumatology at MHAT 'Sveti Georgi'
Start Date
2008-02
Trial ID
NCT00556894